BLRX

BioLineRX

20 hedge funds and large institutions have $2.91M invested in BioLineRX in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$1.03M
2 -$730K
3 -$135K
4
AWS
Atria Wealth Solutions
New York
-$2.66K
5
UBS Group
UBS Group
Switzerland
-$2.26K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.02M
2
$228K
3
$114K
4
$104K
5
$97.8K
6
$94K
7
$87.7K
8
$28.1K
9
$27.4K
10
$21.4K
11
$20.9K
12
$17.7K
13
$14.8K
14
$14.2K
15
$12.9K
16
$3.81K
17
$2.71K
18
$2K
19
$31
20
21